CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites
Global inhibition of NHEJ factors has been one strategy to improve CRISPR-Cas9 mediated HDR. Here the authors fuse a dominant-negative mutant of 53BP1 to Cas9 to enhance HDR frequency, reduce NHEJ specifically at the Cas9 cut sites, and reduce the toxicity associated with global NHEJ inhibition.
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af6eb1ef193d4ac7958e34f1c42a6fa1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:af6eb1ef193d4ac7958e34f1c42a6fa1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:af6eb1ef193d4ac7958e34f1c42a6fa12021-12-02T14:35:44ZCRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites10.1038/s41467-019-10735-72041-1723https://doaj.org/article/af6eb1ef193d4ac7958e34f1c42a6fa12019-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-10735-7https://doaj.org/toc/2041-1723Global inhibition of NHEJ factors has been one strategy to improve CRISPR-Cas9 mediated HDR. Here the authors fuse a dominant-negative mutant of 53BP1 to Cas9 to enhance HDR frequency, reduce NHEJ specifically at the Cas9 cut sites, and reduce the toxicity associated with global NHEJ inhibition.Rajeswari JayavaradhanDevin M. PillisMichael GoodmanFan ZhangYue ZhangPaul R. AndreassenPunam MalikNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-13 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Rajeswari Jayavaradhan Devin M. Pillis Michael Goodman Fan Zhang Yue Zhang Paul R. Andreassen Punam Malik CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites |
description |
Global inhibition of NHEJ factors has been one strategy to improve CRISPR-Cas9 mediated HDR. Here the authors fuse a dominant-negative mutant of 53BP1 to Cas9 to enhance HDR frequency, reduce NHEJ specifically at the Cas9 cut sites, and reduce the toxicity associated with global NHEJ inhibition. |
format |
article |
author |
Rajeswari Jayavaradhan Devin M. Pillis Michael Goodman Fan Zhang Yue Zhang Paul R. Andreassen Punam Malik |
author_facet |
Rajeswari Jayavaradhan Devin M. Pillis Michael Goodman Fan Zhang Yue Zhang Paul R. Andreassen Punam Malik |
author_sort |
Rajeswari Jayavaradhan |
title |
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites |
title_short |
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites |
title_full |
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites |
title_fullStr |
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites |
title_full_unstemmed |
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites |
title_sort |
crispr-cas9 fusion to dominant-negative 53bp1 enhances hdr and inhibits nhej specifically at cas9 target sites |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/af6eb1ef193d4ac7958e34f1c42a6fa1 |
work_keys_str_mv |
AT rajeswarijayavaradhan crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites AT devinmpillis crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites AT michaelgoodman crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites AT fanzhang crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites AT yuezhang crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites AT paulrandreassen crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites AT punammalik crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites |
_version_ |
1718391093671755776 |